CNTX

Context Therapeutics Inc.

Insider Trades

NameValueActionPriceCurrent Price
Minai-Azary Jennifer LynnChief Financial Officer
$25k40k shares
BuyJun 6, 2025
$0.637
--
Levit Alex C.Chief Legal Officer, Corp. Sec
$12k20k shares
BuyJun 6, 2025
$0.576
--
Lehr Martin A.Director, Officer: Chief Executive Officer
$70k100k shares
BuyJun 9, 2025
$0.7008
--

News

benzinga.comSmall Biotech Context Therapeutics Reports 29% Response Rate In Ovarian Cancer Studybenzinga.comJun 15globenewswire.comContext Therapeutics Announces Positive Interim Efficacy and Safety Results from Ongoing Phase 1 Clinical Trial for CTIM-76globenewswire.comJun 15globenewswire.comContext Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)globenewswire.comJun 9globenewswire.comContext Therapeutics to Present at the Jefferies Global Healthcare Conferenceglobenewswire.comMay 27globenewswire.comContext Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202globenewswire.comMay 18